$IDPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOGEN INC.. Get notifications about new insider transactions in BIOGEN INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 34 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 05 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 319.35 | 54 | 17,245 | 4,542 | 4.6 K to 4.5 K (-1.17 %) |
Dec 05 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 400 | 0 | 5,134 | 5.5 K to 5.1 K (-7.23 %) |
Dec 05 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 200 | 0 | 5,534 | 5.7 K to 5.5 K (-3.49 %) |
Dec 05 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 250 | 0 | 5,734 | 6 K to 5.7 K (-4.18 %) |
Nov 30 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 319.84 | 10,000 | 3,198,400 | 413,858 | 403.9 K to 413.9 K (+2.48 %) |
Nov 30 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 316.12 | 20,000 | 6,322,400 | 403,858 | 383.9 K to 403.9 K (+5.21 %) |
Aug 31 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 316.56 | 933 | 295,350 | 383,858 | 382.9 K to 383.9 K (+0.24 %) |
Aug 03 2017 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 1,280 | 0 | 1,280 | |
Aug 03 2017 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Grant | A | 0.00 | 860 | 0 | 860 | 0 to 860 |
Jul 26 2017 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Sell | S | 290.01 | 4,974 | 1,442,510 | 22,258 | 27.2 K to 22.3 K (-18.27 %) |
Jul 20 2017 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Cor ... | Sell | S | 285.00 | 7,758 | 2,211,030 | 27,232 | 35 K to 27.2 K (-22.17 %) |
Jul 05 2017 | IDPH | BIOGEN INC. | Kress Jean-Paul | EVP Pres Int'l & Gl ... | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
Jun 12 2017 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 256.31 | 1,084 | 277,840 | 6,330 | 7.4 K to 6.3 K (-14.62 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 1,055 | 0 | 14,144 | 13.1 K to 14.1 K (+8.06 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Grant | A | 0.00 | 1,055 | 0 | 18,172 | 17.1 K to 18.2 K (+6.16 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | Mulligan Richard | Director | Grant | A | 0.00 | 1,055 | 0 | 10,029 | 9 K to 10 K (+11.76 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 1,055 | 0 | 5,984 | 4.9 K to 6 K (+21.40 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,740 | 0 | 19,946 | 18.2 K to 19.9 K (+9.56 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Grant | A | 0.00 | 1,055 | 0 | 17,707 | 16.7 K to 17.7 K (+6.34 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | LEAMING NANCY | Director | Grant | A | 0.00 | 1,055 | 0 | 10,063 | 9 K to 10.1 K (+11.71 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 1,055 | 0 | 7,414 | 6.4 K to 7.4 K (+16.59 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | SCHENK LYNN | Director | Grant | A | 0.00 | 1,055 | 0 | 7,029 | 6 K to 7 K (+17.66 %) |
Jun 09 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,055 | 0 | 10,029 | 9 K to 10 K (+11.76 %) |
Jun 05 2017 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | J | 0.00 | 1,235 | 0 | 4,996 | |
Jun 05 2017 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | M | 0.00 | 1,259 | 0 | 6,231 | |
Jun 05 2017 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 252.38 | 411 | 103,728 | 3,616 | 4 K to 3.6 K (-10.21 %) |
Jun 05 2017 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Buy | M | 0.00 | 1,259 | 0 | 4,027 | 2.8 K to 4 K (+45.48 %) |
Jun 05 2017 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 252.38 | 336 | 84,800 | 2,768 | 3.1 K to 2.8 K (-10.82 %) |
May 04 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 1,508 | 0 | 6,496 | |
May 04 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,736 | 0 | 8,004 | |
May 04 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 271.34 | 564 | 153,036 | 4,099 | 4.7 K to 4.1 K (-12.10 %) |
May 04 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 1,736 | 0 | 4,663 | 2.9 K to 4.7 K (+59.31 %) |
May 01 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 278.48 | 58,858 | 16,390,776 | 383,858 | 325 K to 383.9 K (+18.11 %) |
May 01 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 278.58 | 15,000 | 4,178,700 | 325,000 | 310 K to 325 K (+4.84 %) |
Apr 27 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 290.00 | 9,892 | 2,868,680 | 10,813 | 20.7 K to 10.8 K (-47.78 %) |
Apr 04 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 274.08 | 1,981 | 542,952 | 7,060 | 9 K to 7.1 K (-21.91 %) |
Mar 14 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 291.55 | 9,891 | 2,883,721 | 20,705 | 30.6 K to 20.7 K (-32.33 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,873 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 1,152 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,092 | 0 | 7,546 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 663 | 0 | 1,774 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,105 | 0 | 2,437 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,678 | 0 | 9,638 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,352 | 0 | 1,152 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 274.76 | 1,352 | 371,476 | 30,596 | 31.9 K to 30.6 K (-4.23 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,873 | 0 | 31,948 | 29.1 K to 31.9 K (+9.88 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 274.76 | 543 | 149,195 | 29,075 | 29.6 K to 29.1 K (-1.83 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 1,152 | 0 | 29,618 | 28.5 K to 29.6 K (+4.05 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 287.63 | 847 | 243,623 | 28,466 | 29.3 K to 28.5 K (-2.89 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,092 | 0 | 29,313 | 27.2 K to 29.3 K (+7.69 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 284.75 | 312 | 88,842 | 27,221 | 27.5 K to 27.2 K (-1.13 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 663 | 0 | 27,533 | 26.9 K to 27.5 K (+2.47 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 815 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 628 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,569 | 0 | 6,828 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 398 | 0 | 1,062 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,375 | 0 | 4,960 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 662 | 0 | 1,460 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,103 | 0 | 6,335 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 738 | 0 | 628 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,841 | 0 | 8,397 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 384 | 105,508 | 10,014 | 10.4 K to 10 K (-3.69 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 815 | 0 | 10,398 | 9.6 K to 10.4 K (+8.50 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.60 | 296 | 81,282 | 9,583 | 9.9 K to 9.6 K (-3.00 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 628 | 0 | 9,879 | 9.3 K to 9.9 K (+6.79 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 739 | 203,048 | 9,251 | 10 K to 9.3 K (-7.40 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,569 | 0 | 9,990 | 8.4 K to 10 K (+18.63 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 727 | 199,751 | 8,421 | 9.1 K to 8.4 K (-7.95 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 284.75 | 188 | 53,533 | 9,148 | 9.3 K to 9.1 K (-2.01 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 398 | 0 | 9,336 | 8.9 K to 9.3 K (+4.45 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 287.63 | 647 | 186,097 | 8,938 | 9.6 K to 8.9 K (-6.75 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,375 | 0 | 9,585 | 8.2 K to 9.6 K (+16.75 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 121 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 321 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 163 | 0 | 596 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 76 | 0 | 208 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 128 | 0 | 284 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 131 | 0 | 759 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 143 | 0 | 121 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 274.76 | 3 | 824 | 4,505 | 4.5 K to 4.5 K (-0.07 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 121 | 0 | 4,508 | 4.4 K to 4.5 K (+2.76 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 274.76 | 8 | 2,198 | 4,387 | 4.4 K to 4.4 K (-0.18 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 321 | 0 | 4,395 | 4.1 K to 4.4 K (+7.88 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 287.63 | 53 | 15,244 | 4,074 | 4.1 K to 4.1 K (-1.28 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 163 | 0 | 4,127 | 4 K to 4.1 K (+4.11 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 284.75 | 25 | 7,119 | 3,964 | 4 K to 4 K (-0.63 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 76 | 0 | 3,989 | 3.9 K to 4 K (+1.94 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | M | 0.00 | 1,494 | 0 | 5,392 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | M | 0.00 | 570 | 0 | 1,522 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | J | 0.00 | 952 | 0 | 2,092 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | J | 0.00 | 1,198 | 0 | 6,886 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 287.63 | 485 | 139,501 | 8,752 | 9.2 K to 8.8 K (-5.25 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Buy | M | 0.00 | 1,494 | 0 | 9,237 | 7.7 K to 9.2 K (+19.29 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 284.75 | 253 | 72,042 | 7,743 | 8 K to 7.7 K (-3.16 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Buy | M | 0.00 | 570 | 0 | 7,996 | 7.4 K to 8 K (+7.68 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,300 | 0 | 1 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 1,174 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 1,494 | 0 | 5,392 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 728 | 0 | 1,948 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,216 | 0 | 2,676 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,198 | 0 | 6,886 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,378 | 0 | 1,174 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 274.76 | 1,083 | 297,565 | 7,177 | 8.3 K to 7.2 K (-13.11 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,300 | 0 | 8,260 | 6 K to 8.3 K (+38.59 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 274.76 | 553 | 151,942 | 5,960 | 6.5 K to 6 K (-8.49 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 1,174 | 0 | 6,513 | 5.3 K to 6.5 K (+21.99 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 287.63 | 485 | 139,501 | 5,339 | 5.8 K to 5.3 K (-8.33 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 1,494 | 0 | 5,824 | 4.3 K to 5.8 K (+34.50 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 284.75 | 335 | 95,391 | 4,330 | 4.7 K to 4.3 K (-7.18 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 728 | 0 | 4,665 | 3.9 K to 4.7 K (+18.49 %) |
Mar 01 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | P | 285.39 | 1,333 | 380,425 | 1,434 | 101 to 1.4 K (+1,319.80 %) |
Feb 17 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | A | 0.00 | 6,380 | 0 | 6,380 | |
Feb 17 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | A | 0.00 | 25,500 | 0 | 25,500 | |
Feb 17 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 7,650 | 0 | 7,650 | |
Feb 17 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | A | 0.00 | 5,100 | 0 | 5,100 | |
Feb 17 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 770 | 0 | 770 | |
Feb 17 2017 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | A | 0.00 | 8,160 | 0 | 8,160 | |
Feb 17 2017 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 7,010 | 0 | 7,010 | |
Feb 17 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | A | 0.00 | 6,380 | 0 | 6,380 | |
Feb 17 2017 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 8,160 | 0 | 8,160 | |
Feb 01 2017 | IDPH | BIOGEN INC. | BIOGEN INC. | 10% Owner | Sell | J | 0.00 | 107,975,968 | 0 | 0 | 108 M to 0 (-100.00 %) |
Jan 10 2017 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Option Exercise | M | 52.22 | 5,450 | 284,599 | 0 | |
Jan 10 2017 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Sell | S | 295.39 | 5,450 | 1,609,876 | 16,628 | 22.1 K to 16.6 K (-24.69 %) |
Jan 10 2017 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Buy | M | 52.22 | 5,450 | 284,599 | 22,078 | 16.6 K to 22.1 K (+32.78 %) |
Dec 05 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Sell | S | 296.53 | 48 | 14,233 | 7,360 | 7.4 K to 7.4 K (-0.65 %) |
Dec 05 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 295.78 | 171 | 50,578 | 7,408 | 7.6 K to 7.4 K (-2.26 %) |
Dec 05 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 295.78 | 53 | 15,676 | 3,884 | 3.9 K to 3.9 K (-1.35 %) |
Dec 05 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Grant | A | 0.00 | 930 | 0 | 3,937 | 3 K to 3.9 K (+30.93 %) |
Nov 14 2016 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Gift | G | 0.00 | 1,000 | 0 | 4,905 | 5.9 K to 4.9 K (-16.93 %) |
Oct 05 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Sell | S | 311.94 | 262 | 81,728 | 7,579 | 7.8 K to 7.6 K (-3.34 %) |
Oct 04 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | J | 0.00 | 2,280 | 0 | 4,266 | |
Oct 04 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | M | 0.00 | 1,982 | 0 | 6,546 | |
Oct 04 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Sell | S | 313.00 | 380 | 118,940 | 7,841 | 8.2 K to 7.8 K (-4.62 %) |
Oct 04 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 313.03 | 933 | 292,057 | 8,221 | 9.2 K to 8.2 K (-10.19 %) |
Oct 04 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Buy | M | 0.00 | 1,982 | 0 | 9,154 | 7.2 K to 9.2 K (+27.64 %) |
Oct 04 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 313.03 | 955 | 298,944 | 7,172 | 8.1 K to 7.2 K (-11.75 %) |
Sep 26 2016 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Option Exercise | M | 53.64 | 25,000 | 1,341,000 | 0 | |
Sep 26 2016 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Option Exercise | M | 53.64 | 2,570 | 137,855 | 0 | |
Sep 26 2016 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Sell | S | 314.00 | 27,570 | 8,656,980 | 17,093 | 44.7 K to 17.1 K (-61.73 %) |
Sep 26 2016 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Buy | M | 53.64 | 25,000 | 1,341,000 | 44,663 | 19.7 K to 44.7 K (+127.14 %) |
Sep 26 2016 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Buy | M | 53.64 | 2,570 | 137,855 | 19,663 | 17.1 K to 19.7 K (+15.04 %) |
Jul 22 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 280.00 | 157 | 43,960 | 54,779 | 54.9 K to 54.8 K (-0.29 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,060 | 0 | 8,950 | 7.9 K to 9 K (+13.43 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 1,060 | 0 | 5,905 | 4.8 K to 5.9 K (+21.88 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | SCHENK LYNN | Director | Grant | A | 0.00 | 1,060 | 0 | 5,950 | 4.9 K to 6 K (+21.68 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 1,060 | 0 | 13,065 | 12 K to 13.1 K (+8.83 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,590 | 0 | 18,170 | 16.6 K to 18.2 K (+9.59 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | Mulligan Richard | Director | Grant | A | 0.00 | 1,060 | 0 | 8,950 | 7.9 K to 9 K (+13.43 %) |
Jun 09 2016 | IDPH | BIOGEN INC. | LEAMING NANCY | Director | Grant | A | 0.00 | 1,060 | 0 | 8,984 | 7.9 K to 9 K (+13.38 %) |